SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments???
BSX 100.72+0.1%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MJ who wrote (782)11/29/2001 2:31:24 PM
From: Lighthouse  Read Replies (1) of 798
 
I exited the stock a point or two ago. Probably early but I will take my gain. I switched to ANPI, but not on a one for one basis. In reality it is the same play as holding BSX here, but with much much more leverage. If paclitaxel stents prove effective and take 20% plus market share then ANPI (which supplies both Cook and BSX with pac-stents) should respond. If paclitaxel-stents lose out to JNJ's then this is a complete and utter wipe out. The market appears ready to believe BSX has a stent future - we shall see.

People reading this should do their own due diligence as the author is unknown and could be unreasonable, malicious or just plain retarded. Be careful what you read on these public boards.

Cheers,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext